tirzepatide osa approval in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification? Tirzepatide for sleep-disordered breathing in
Description
Introducing The CardioNerds Mon, 09 Dec 2019 04:46:00 +0000 Amit Goyal, Daniel Ambinder, and Clinical Problem Solver host Reza Manesh introduce The CardioNerds podcast and the CardioNerd mission
The Flexibility of Tirzepatide Dosing Tirzepatide is a once-weekly injectable medication that belongs to a class of drugs known as dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonists
Our comparative findings simplify the interpretation of outcomes in thousands of people studied in the PIONEER and SUSTAIN clinical trials
He is an Associate of the American College of Cardiology (AACC), completed his fellowship in 2018, and is a board-certified family practitioner
Others have the opposite experience
